Form 4 for CTMX CytomX Therapeutics, Inc.
Accepted 2022-07-21 00:00:00 ET · period of report 2022-07-19 · accession 0001567619-22-014296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-21 | 2022-07-19 | CTMX | Campoy Carlos | CFO | A - Grant | $0.00 | +15.0K | 43.9K | +52% | $0 | |
| 2022-07-21 | 2022-07-20 | CTMX | Campoy Carlos | CFO | S - Sale | $1.42 | -3,949 | 40.0K | -9% | -$5,608 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-19 | A | A | 15,000 | $0.00 | 43,921 | D | — | — | (F2) Includes 22,500 restricted stock units. |
| 2 | Common | Common Stock | 2022-07-20 | S | D | 3,949 | $1.42 | 39,972 | D | — | — | (F2) Includes 22,500 restricted stock units. |